Sms Lifesciences India Ltd, based in India, is a pharmaceutical company.
One of their notable products is ALLOPURINOL, with a corresponding US DMF Number 36130.
Remarkably, this DMF maintains an Active status since its submission on November 28, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 24, 2023, and payment made on October 03, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II